Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications

BJB Nelson, JD Andersson, F Wuest - Pharmaceutics, 2020 - mdpi.com
This review outlines the accomplishments and potential developments of targeted alpha (α)
particle therapy (TAT). It discusses the therapeutic advantages of the short and highly …

α-emitters for radiotherapy: from basic radiochemistry to clinical studies—part 1

S Poty, LC Francesconi, MR McDevitt… - Journal of Nuclear …, 2018 - Soc Nuclear Med
With a short particle range and high linear energy transfer, α-emitting radionuclides
demonstrate high cell-killing efficiencies. Even with the existence of numerous radionuclides …

A critical review of alpha radionuclide therapy—how to deal with recoiling daughters?

RM De Kruijff, HT Wolterbeek, AG Denkova - Pharmaceuticals, 2015 - mdpi.com
This review presents an overview of the successes and challenges currently faced in alpha
radionuclide therapy. Alpha particles have an advantage in killing tumour cells as compared …

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

S Poty, LM Carter, K Mandleywala, R Membreno… - Clinical Cancer …, 2019 - AACR
Purpose: Interest in targeted alpha-therapy has surged due to α-particles' high cytotoxicity.
However, the widespread clinical use of this approach could be limited by on-/off-target …

[HTML][HTML] Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review

F De Felice, A Polimeni, V Valentini, O Brugnoletti… - Neoplasia, 2018 - Elsevier
In treating head and neck cancer (HNC), the objectives are provided for best functional
results and minimal risk of serious complications. The choice of appropriate management …

Alpha dose modeling in diffusing alpha‐emitters radiation therapy—Part I: single‐seed calculations in one and two dimensions

G Heger, A Roy, M Dumančić, L Arazi - Medical Physics, 2023 - Wiley Online Library
Abstract Background Diffusing alpha‐emitters Radiation Therapy (“DaRT”) is a new method,
presently in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies …

[HTML][HTML] Initial safety and tumor control results from a “first-in-human” multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of …

A Popovtzer, E Rosenfeld, A Mizrachi, SR Bellia… - International Journal of …, 2020 - Elsevier
Purpose Our purpose was to report the feasibility and safety of diffusing alpha-emitter
radiation therapy (DaRT), which entails the interstitial implantation of a novel alpha-emitting …

The potentiation of anti-tumor immunity by tumor abolition with alpha particles, protons, or carbon ion radiation and its enforcement by combination with …

Y Keisari, I Kelson - Cells, 2021 - mdpi.com
The delivery of radiation therapy (RT) for cancer with intent to cure has been optimized and
standardized over the last 80 years. Both preclinical and clinical work emphasized the …

Recent insights in barium-131 as a diagnostic match for radium-223: Cyclotron production, separation, radiolabeling, and imaging

F Reissig, D Bauer, M Ullrich, M Kreller, J Pietzsch… - Pharmaceuticals, 2020 - mdpi.com
Barium-131 is a single photon emission computed tomography (SPECT)-compatible
radionuclide for nuclear medicine and a promising diagnostic match for radium-223/-224 …

Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications

BJB Nelson, J Wilson, JD Andersson, F Wuest - Pharmaceuticals, 2023 - mdpi.com
This article highlights recent developments of SPECT and PET diagnostic imaging
surrogates for targeted alpha particle therapy (TAT) radiopharmaceuticals. It outlines the …